Clinical Trials Directory

Trials / Completed

CompletedNCT05561543

Effects of Peppermint Oil in Mild-moderate Hypertension.

Effects of Peppermint Oil in Cardiometabolic Outcomes in Participants With Mild-moderate Hypertension.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Central Lancashire · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Cardiovascular and associated hypertensive diseases are the leading health burden and cause of mortality worldwide; therefore, the necessity for effective interventions is paramount. Dietary interventions to improve cardiovascular health are highly sought after as they possess less risk and financial burden than pharmacological drugs. Our previous randomized trial has shown that oral peppermint can improving systolic blood pressure and other cardiovascular/ blood lipids in healthy individuals. However, to date, no research has explored this using a placebo randomized intervention in patients with hypertension. Therefore, the primary purpose of the proposed investigation is to test the ability of oral peppermint oil supplementation to improve cardiometabolic parameters in participants with mild-moderate hypertension.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPeppermint oilPeppermint oil
OTHERPlaceboPlacebo

Timeline

Start date
2024-01-01
Primary completion
2025-08-01
Completion
2025-08-10
First posted
2022-09-30
Last updated
2026-01-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05561543. Inclusion in this directory is not an endorsement.